For a long time, science has been divided in different disciplines. Now the walls are coming down: Skills and technologies from fields like biology, engineering and digitalization are coming together to lift health care and life sciences to the next level. CSEM is positioned in the middle of this new megatrend called bioconvergence.
«Bioconvergence is transforming health care and biotech industry, development and manufacturing», say Samantha Paoletti & Gilles Weder, Co-Heads of Research & Business Development for the Life Sciences Technologies at CSEM.
The interdisciplinary collaboration between different fields of science and technology will open the door for innovative solutions for personalized healthcare, Biotech and pharmaceutical research. «These new applications will be made faster and more affordable through standardization, parallelization and artificial intelligence as we transition from manual to automated workflows.»
Advantages of the bioconvergence approach for the economy
- Individualized solutions precisely tailored to each patient’s needs
- Faster and more affordable tests and therapies thanks to automation, parallelization and AI
- More standardized, more reliable results in test environments using human material like organoids
- Advanced diagnostics to detect diseases earlier
- Sustainability for environmental management and sustainable practices.
- Less animal testing (promoting 3R principles and avoiding future legal issues)
CSEM provides the perfect ecosystem for bioconvergence
At CSEM «all the ingredients for systematic collaboration and interdisciplinary projects are already in place» says Alexandre Pauchard, CSEM's CEO.
Our expertise in cells and body fluids is complemented by the activities of CSEM Digital Health which focuses on the development of medical wearables to prevent diseases, monitor at-risk patients, and enhance behavioral changes.
Put together, people, experience, know-how and facilities add up to a perfect ecosystem for bioconvergence for the healthcare sector.
Customer-centricity & Industry-orientation
- Collaboration with partners from emerging and large biotech / pharma industry, start-ups and clinics, tech transfer, safety & regulations, development stages from prototyping to pre-industrial scale-up, ...
Know-how & Experience at CSEM
- Staff with industry experience
- Precision liquid handling, smart labware, microsystems, single cell analysis, cellomics, organoids, OoC, microfluidics, automation, Al, data, sensors, biomaterials, ...
Facilities & Processes
at CSEM
- Cell culture laboratories BSL2, Cleanrooms, MEMS foundry
- Processes with built-in confidentiality, QMS and Certifications (ISO 9001 and 14001, ISO 13485: Medical Devices)
CSEM showcase for bioconvergence projects
The CSEM Tools for life sciences team is already successfully collaborating with partners from start-ups and the biotech/pharma industry from all regions of Switzerland. Here a few examples that showcase what is possible if skills and technologies from different fields converge:
Timeline Tools for Life Sciences Developments
Come and meet us in person
Networking and collaboration are at the heart of innovation in Life Sciences. We organize several events in Switzerland and showcase our cutting-edge developments in laboratory automation, biomonitoring, and single-cell technologies to exhibits at the national and international level.
Dive into insightful conversations and discover how our innovations can elevate your bioprocessing capabilities.
We're eager to connect with fellow professionals and share our passion for advancing life sciences together! See you there!
Partnering up for bioconvergence?
Contact us to learn more about what we have to offer. Whether you’re looking for a partner to bring your ideas to life or to accelerate an ongoing project, we’re here to help.
Collaborating with clinicians and hospitals is a priority for us, as it allows us to further center our work around the needs of patients.
We look forward to hearing from you!